BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Argus Health
AstraZeneca
McKinsey
Deloitte
McKesson
Fish and Richardson
Citi
Merck

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,114,909

« Back to Dashboard

Which drugs does patent 8,114,909 protect, and when does it expire?

Patent 8,114,909 protects HORIZANT and is included in one NDA.

This patent has twenty-two patent family members in fifteen countries.
Summary for Patent: 8,114,909
Title:Treating or preventing restless legs syndrome using prodrugs of GABA analogs
Abstract: Disclosed herein are methods of using prodrugs of gamma aminobutyric acid (GABA) analogs and pharmaceutical compositions thereof to treat or prevent restless legs syndrome in humans, and pharmaceutical compositions of prodrugs of GABA analogs useful in treating or preventing restless legs syndrome.
Inventor(s): Barrett; Ronald W. (Saratoga, CA), Canafax; Daniel M. (Half Moon Bay, CA)
Assignee: XenoPort, Inc. (Santa Clara, CA)
Application Number:10/969,196
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 8,114,909

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-002 Dec 13, 2011 RX Yes No ➤ Subscribe ➤ Subscribe TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS ➤ Subscribe
Arbor Pharms Llc HORIZANT gabapentin enacarbil TABLET, EXTENDED RELEASE;ORAL 022399-001 Apr 6, 2011 RX Yes Yes ➤ Subscribe ➤ Subscribe TREATMENT OF MODERATE-TO-SEVERE PRIMARY RESTLESS LEG SYNDROME IN ADULTS ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,114,909

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004274002 ➤ Subscribe
Brazil PI0414481 ➤ Subscribe
Canada 2538802 ➤ Subscribe
China 1871021 ➤ Subscribe
European Patent Office 1677812 ➤ Subscribe
Israel 174282 ➤ Subscribe
Israel 200687 ➤ Subscribe
Japan 2007511464 ➤ Subscribe
Japan 5107576 ➤ Subscribe
South Korea 101157436 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Farmers Insurance
Mallinckrodt
Merck
Queensland Health
McKesson
McKinsey
Medtronic
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot